Diana Chang Blanc

Dear All:

With thanks to all who contributed, the NDVP version 2.0 is now on-line and can be found at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccine-deployment-2021.1-eng

The updated (second) version of the WHO-UNICEF “Guidance on developing a national deployment and vaccination plan (NDVP)” for COVID-19 vaccines. This version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:

• the COVID-19 Partners Platform;
• the use of COVID-19 simulation exercises to test deployment strategies;
• the indemnity agreement and no-fault compensation programme for vaccines secured through the COVAX Facility in the Advance Market Commitment (AMC) eligible economies;
• the availability and use of the WHO-UNICEF COVID-19 Vaccine Introduction and deployment Costing (CVIC) tool;
• the COVAX Facility’s humanitarian buffer that enables allocation of vaccine to cover high-risk populations in humanitarian settings;
• recommendations for vaccination of pregnant and lactating women;
• supplementary information on infection prevention and control (IPC) measures to be used to deliver COVID-19 vaccines safely;
• the WHO licensed COVID-19 vaccines product-specific information;
• use of geospatial data and digital micro plans for equitable access and delivery of COVID-19 vaccines;
• lessons learned from the development of NDVPs and early experiences in COVID-19 vaccine deployment in countries; and
• updated additional resources at the end of each chapter.